ISSN: 1300 - 6525 E-ISSN: 2149 - 0880
kulak burun boğaz
ve baş boyun cerrahisi dergisi
http://dergi.kbb-bbc.org.tr
Koşulsuz Destek Verenler
Kayıtlı İndeksler





REVIEW ARTICLES

Autoimmune Inner Ear Disease Secondary to Hashimato’s Thyroiditis: A Literature Review
Otoimmün İç Kulak Hastalığı ve Hashimoto Tiroiditi İlişkisi: Literatür Derlemesi
Received Date : 16 Jun 2021
Accepted Date : 07 Sep 2021
Available Online : 14 Sep 2021
Doi: 10.24179/kbbbbc.2021-85022 - Makale Dili: TR
KBB ve BBC Dergisi. 2022;30(1):38-44
Copyright © 2020 by Turkey Association of Society of Ear Nose Throat and Head Neck Surgery. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Autoimmune inner ear disease (AIED) is a cause of hearing loss that currently accounts for approximately 1% of all hearing loss cases and its etiopathogenesis is still not clearly defined. AIED may be associated with a systemic autoimmune disease or it may be cochlea-specific. Although Hashimoto's thyroiditis (HT) is a very common autoimmune disease, its relationship with hearing loss is less known than the relationship between other systemic autoimmune diseases and hearing loss. Not only cochlear but also central hearing loss due to HT has been reported. No improvement in hearing loss was observed with treatment of thyroid dysfunction. In this article, we aimed to compile the data obtained from studies investigating the relationship between HT and AIED in the literature.
ÖZET
Otoimmün iç kulak hastalığı (OİKH), günümüzde tüm işitme kaybı vakalarının yaklaşık %1’ini oluşturan ve etiyopatogenezi hâlâ net olarak ortaya konulamamış bir işitme kaybı nedenidir. OİKH, sistemik otoimmün bir hastalıkla birlikte olabileceği gibi kohleaya özgü de olabilmektedir. Hashimoto tiroiditi (HT) oldukça yaygın bir otoimmün hastalık olmasına rağmen işitme kaybı ile ilişkisi, diğer daha nadir görülen sistemik otoimmün hastalıkların işitme kaybı ile aralarındaki ilişkiye kıyasla daha az bilinmektedir. HT’ye bağlı sadece kohlear değil santral işitme kaybı da bildirilmiştir. Tiroidfonksiyon bozukluğunun tedavisiyle işitme kaybında herhangi bir iyileşme gözlenmemiştir. Bu yazımızda, literatürde bugüne kadar HT-OİKH ilişkisini araştıran çalışmalardan edinilen verileri derlemeyi amaçladık.
KAYNAKLAR
  1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1979;88(5 Pt 1):585-9. [Crossref]  [PubMed] 
  2. Renda L, Parlak M, Selçuk ÖT, Renda R, Eyigör H, Yılmaz MD, et al. Do antithyroid antibodies affect hearing outcomes in patients with pediatric euthyroid Hashimoto's thyroiditis? Int J Pediatr Otorhinolaryngol. 2015; 79(12):2043-9. [Crossref]  [PubMed] 
  3. Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81(4):483-8. [Crossref]  [PubMed] 
  4. Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg. 2004;12(5):426-30. [Crossref]  [PubMed] 
  5. Berrocal JR, Ramírez-Camacho R. Sudden sensorineural hearing loss: supporting the immunologic theory. Ann Otol Rhinol Laryngol. 2002;111(11):989-97. [Crossref]  [PubMed] 
  6. Harris JP, Ryan AF. Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg. 1995;112(6):639-53. [Crossref]  [PubMed] 
  7. Mijovic T, Zeitouni A, Colmegna I. Autoimmune sensorineural hearing loss: the otology-rheumatology interface. Rheumatology (Oxford). 2013;52(5):780-9. [Crossref]  [PubMed] 
  8. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Practical versus theoretical management of autoimmune inner ear disease. Laryngoscope. 1984;94(6):758-67. [Crossref]  [PubMed] 
  9. Malik MU, Pandian V, Masood H, Diaz DA, Varela V, Dávalos-Balderas AJ, et al. Spectrum of immune-mediated inner ear disease and cochlear implant results. Laryngoscope. 2012;122(11):2557-62. [Crossref]  [PubMed] 
  10. Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, et al. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649. [Crossref]  [PubMed] 
  11. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119-25. [Crossref]  [PubMed] 
  12. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-65. [Crossref]  [PubMed] 
  13. Tsai YT, Chang IJ, Hsu CM, Yang YH, Liu CY, Tsai MS, et al. Association between Sudden Sensorineural Hearing Loss and Preexisting Thyroid Diseases: A Nationwide Case-Control Study in Taiwan. Int J Environ Res Public Health. 2020;17(3):834. [Crossref]  [PubMed]  [PMC] 
  14. Berker D, Karabulut H, Isik S, Tutuncu Y, Ozuguz U, Erden G, et al. Evaluation of hearing loss in patients with Graves' disease. Endocrine. 2012;41(1):116-21. [Crossref]  [PubMed] 
  15. Thornton AR, Jarvis SJ. Auditory brainstem response findings in hypothyroid and hyperthyroid disease. Clin Neurophysiol. 2008;119(4): 786-90. [Crossref]  [PubMed] 
  16. Werneck AL, Gurgel LC, de Mello LM, de Albuquerque GQ. Sudden sensorineural hearing loss: a case report supporting the immuno logic theory. Arq Neuropsiquiatr. 2003;61(4): 1018-22. [Crossref]  [PubMed] 
  17. Uziel A, Marot M, Rabie A. Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. II. Electrophysiological study. Brain Res. 1985; 351(1):123-7. [Crossref]  [PubMed] 
  18. Santos KT, Dias NH, Mazeto GM, Carvalho LR, Lapate RL, Martins RH. Audiologic evaluation in patients with acquired hypothyroidism. Braz J Otorhinolaryngol. 2010;76(4):478-84. English, Portuguese. [Crossref]  [PubMed] 
  19. Arduc A, Isık S, Allusoglu S, Iriz A, Dogan BA, Gocer C, et al. Evaluation of hearing functions in patients with euthyroid Hashimoto's thyroiditis. Endocrine. 2015;50(3):708-14. [Crossref]  [PubMed] 
  20. Brenner M, Hoistad DL, Hain TC. Prevalence of thyroid dysfunction in patients with Ménière's disease. Arch Otolaryngol Head Neck Surg. 2004;130(2):226-8. [Crossref]  [PubMed] 
  21. Modugno GC, Pirodda A, Ferri GG, Montana T, Rasciti L, Ceroni AR. A relationship between autoimmune thyroiditis and benign paroxysmal positional vertigo? Med Hypotheses. 2000;54(4):614-5. [Crossref]  [PubMed] 
  22. Chiarella G, Tognini S, Nacci A, Sieli R, Costante G, Petrolo C, et al. Vestibular disorders in euthyroid patients with Hashimoto's thyroiditis: role of thyroid autoimmunity. Clin Endocrinol (Oxf). 2014;81(4):600-5. [Crossref]  [PubMed] 
  23. Fayyaz B, Upreti S. Autoimmune inner ear disease secondary to Hashimoto's thyroiditis: a case report. J Community Hosp Intern Med Perspect. 2018;8(4):227-9. [Crossref]  [PubMed]  [PMC] 
  24. Bossowski A, Moniuszko M, Dąbrowska M, Sawicka B, Rusak M, Jeznach M, et al. Lower proportions of CD4+CD25(high) and CD4+ FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases. Autoimmunity. 2013; 46(3):222-30. [Crossref]  [PubMed] 
  25. Rodríguez-Valiente A, Álvarez-Montero Ó, Górriz-Gil C, García-Berrocal JR. l-Thyroxine does not prevent immunemediated sensorineural hearing loss in autoimmune thyroid diseases. Acta Otorrinolaringol Esp (Engl Ed). 2019;70(4):229-34. English, Spanish. [Crossref]  [PubMed] 
  26. Ramírez-Camacho R, García-Berrocal JR, Trinidad A, González-García JA, Verdaguer JM, Ibá-ez A, et al. Central role of supporting cells in cochlear homeostasis and pathology. Med Hypotheses. 2006;67(3):550-5. [Crossref]  [PubMed] 
  27. Or Koca A, Koca HS, Anil C. The effects of hyperinsulinemia on cochlear functions. Noise Health. 2020;22(106):70-6. [Crossref]  [PubMed]  [PMC] 
  28. Gawron W, Pośpiech L, Noczyńska A, Orendorz-Fraczkowska K. Electrophysiological tests of the hearing organ in Hashimoto's disease. J Pediatr Endocrinol Metab. 2004;17(1): 27-32. [Crossref]  [PubMed] 
  29. Bellman SC, Davies A, Fuggle PW, Grant DB, Smith I. Mild impairment of neuro-otological function in early treated congenital hypothyroidism. Arch Dis Child. 1996;74(3):215-8. [Crossref]  [PubMed]  [PMC] 
  30. Di Lorenzo L, Foggia L, Panza N, Calabrese MR, Motta G, Tranchino G, et al. Auditory brainstem responses in thyroid diseases before and after therapy. Horm Res. 1995;43(5): 200-5. [Crossref]  [PubMed] 
  31. Yoneda M. [Hashimoto's Encephalopathy and Autoantibodies]. Brain Nerve. 2018;70(4):305-14. Japanese. [PubMed] 
  32. Rauch SD. Clinical management of immune-mediated inner-ear disease. Ann N Y Acad Sci. 1997;830:203-10. [Crossref]  [PubMed] 
  33. Lobo DR, García-Berrocal JR, Ramírez-Camacho R. New prospects in the diagnosis and treatment of immune-mediated inner ear disease. World J Methodol. 2014;4(2):91-8. [Crossref]  [PubMed]  [PMC] 
  34. Penêda JF, Lima NB, Monteiro F, Silva JV, Gama R, Condé A. Immune-Mediated Inner Ear Disease: Diagnostic and therapeutic approaches. Acta Otorrinolaringol Esp (Engl Ed). 2019;70(2):97-104. English, Spanish. [Crossref]  [PubMed] 
  35. Mancini P, Atturo F, Di Mario A, Portanova G, Ralli M, De Virgilio A, et al. Hearing loss in autoimmune disorders: Prevalence and therapeutic options. Autoimmun Rev. 2018;17(7): 644-52. [Crossref]  [PubMed] 
  36. Wang JR, Yuen HW, Shipp DB, Stewart S, Lin VY, Chen JM, et al. Cochlear implantation in patients with autoimmune inner ear disease including cogan syndrome: a comparison with age- and sex-matched controls. Laryngoscope. 2010;120(12):2478-83. [Crossref]  [PubMed]